We recently published a list of 7 Consumer Goods and Retail Stocks on Jim Cramer’s Radar. In this article, we are going to ...

Goldman Sachs analyst Davin Thillainathan initiated coverage of Fisher & Paykel Healthcare with a Buy rating and A$42.70 price target The firm sees an acceleration of revenue in the company’s ...

Oppenheimer analyst Rupesh Parikh maintained a Buy rating ... Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products.

DexCom is a leader in the continuous glucose monitoring (CGM) market, or devices that help diabetes patients track their blood glucose levels. The company encountered some issues in 2024 ...

Let's consider two in the healthcare sector ... That's why the stock is a buy this month. Exact Sciences develops innovative cancer diagnostic tests. The company's most popular brand by far ...

Health Catalyst has agreed to buy patient engagement platform provider Upfront Healthcare Services for an initial $86 million in cash and stock. Health Catalyst on Monday said it will pay $41.5 ...

Even in healthcare and other scenarios that would benefit from disinfecting, better alternatives to QACs include hydrogen peroxide, citric acid, and alcohol-based cleaning products. Clean surfaces ...

Here's what the broker is saying about them: This pharmaceuticals company could be an ASX 200 healthcare share to buy this year according ... replacement wound care products in the United States.

“Tariffs may incentivize consumers to buy American-made products, especially among older, conservative groups who already prioritize domestic manufacturing,” Chris Beer, data journalist at ...

including distributors of healthcare products, providers of basic healthcare services and owners and operators of healthcare facilities and organizations. The second group of companies is ...

Disinfecting wipes, though commonly used, may do more harm than good due to toxic ingredients causing skin and respiratory ...